RPRobert J. Pawlosky

Robert J. Pawlosky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert J. Pawlosky has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Norman Salem

    6 shared publications
  • Richard L. Veech

    Laboratory of Metabolic Control, National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Bethesda Maryland USA

    3 shared publications
  • Adolfo Llanos

    From the Laboratory of Membrane Biochemistry and Biophysics (YHL and NS) and the Laboratory of Metabolic Control (RJP), National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD; the Institute of Nutrition and Food Technology, Santiago, Chile (AL, PM, and RU); the Neonatology Unit, Hospital Sótero del Rio, Santiago, Chile (AL and PM); and the London School of Hygiene and Tropical Medicine, London, United Kingdom (RU)

    2 shared publications
  • Joseph R. Hibbeln

    2 shared publications
  • Patricia Mena

    From the Laboratory of Membrane Biochemistry and Biophysics (YHL and NS) and the Laboratory of Metabolic Control (RJP), National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD; the Institute of Nutrition and Food Technology, Santiago, Chile (AL, PM, and RU); the Neonatology Unit, Hospital Sótero del Rio, Santiago, Chile (AL and PM); and the London School of Hygiene and Tropical Medicine, London, United Kingdom (RU)

    2 shared publications
  • Ricardo Uauy

    From the Laboratory of Membrane Biochemistry and Biophysics (YHL and NS) and the Laboratory of Metabolic Control (RJP), National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD; the Institute of Nutrition and Food Technology, Santiago, Chile (AL, PM, and RU); the Neonatology Unit, Hospital Sótero del Rio, Santiago, Chile (AL and PM); and the London School of Hygiene and Tropical Medicine, London, United Kingdom (RU)

    2 shared publications

Latest Publications

  • Open Access

    Effect of Dietary Ketosis and Nicotinamide Riboside on Hippocampal Krebs Cycle Intermediates and Mitochondrial Energetics in a DNA Repair‐Deficient 3xTg/POLβ+/− Alzheimer Disease Mouse Model

    by Robert Pawlosky, Tyler G. Demarest, M. Todd King, Darlene Estrada, Richard L. Veech, Vilhelm A. Bohr

    Alzheimer disease is a neurodegenerative pathology‐modifying mitochondrial metabolism with energy impairments where the effects of biological sex and DNA repair deficiencies are unclear. We investigated the therapeutic potential of dietary ketosis alone or with supplemental nicotinamide riboside (NR) on hippocampal intermediary metabolism and mitochondrial bioenergetics in older male and female wild‐type (Wt) and 3xTgAD‐DNA polymerase‐β‐deficient (3xTg/POLβ+/−) (AD) mice. DNA polymerase‐β is a key enzyme in DNA base excision repair (BER) of oxidative damage that may also contribute to mitochondrial DNA repair. Metabolic alterations imparted by ketosis and/or NR were assessed in 16 male and female groups, 4 Wt and 4 AD. At 73 weeks of age, mice were divided into: (A) carbohydrate diet (Carb); (B) Carb diet with NR (Carb‐NR); (C) Ket diet (Ket); and (D) Ket diet with NR (Ket‐NR) groups and remained on their respective treatments for 12 weeks. Mice were euthanized and hippocampi were rapidly removed and frozen. Glycolytic and TCA cycle intermediates were determined by quantitative GC–MS and the ratios of the mitochondrial free [NADox]/[NADHred] and coenzyme ubiquinone (CoQ/CoQH2) couples and the Gibbs free energy of the Complex I–II system of the electron transport chain (ETC) () were calculated from selected metabolites. Mice in Groups C and D had elevated blood ketones (1–2 mM). In most groupings, male mice had higher concentrations of TCA cycle intermediates than females. Moreover, higher concentrations of fumarate in Wt males were associated with elevations in the ΔG′ of Complex I–II compared to females. In Wt males, NR treatments were associated with elevated concentrations of α‐ketoglutarate and malate and linked to increased energy of Complex I–II. In AD males, both NR treatment and dietary ketosis restored the ΔG′ of Complex I–II, where the ratio of the CoQ/CoQH2 couple was oxidized and the [NADox]/[NADHred] couple was reduced. In AD females, only mice in the Ket diet group had a sufficiently reduced [NADox]/[NADHred] couple to restore the free energy profile. image


  • Open Access

    A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer’s Disease

    by Robert J. Pawlosky, Yoshihero Kashiwaya, M. Todd King, Richard L. Veech

    Because of a decreased sensitivity toward insulin, a key regulator of pyruvate dehydrogenase (PDH), Alzheimer’s patients have lower brain glucose utilization with reductions in Tricarboxylic Acid (TCA) cycle metabolites such as citrate, a precursor to n-acetyl-aspartate. In the 3xTgAd mouse model of Alzheimer’s disease (AD), aging mice also demonstrate low brain glucose metabolism. Ketone metabolism can overcome PDH inhibition and restore TCA cycle metabolites, thereby enhancing amino acid biosynthesis. A ketone ester of d-β-hydroxybutyrate was incorporated into a diet (Ket) and fed to 3xTgAd mice. A control group was fed a calorically matched diet (Cho). At 15 months of age, the exploratory and avoidance-related behavior patterns of the mice were evaluated. At 16.5 months of age, the animals were euthanized, and their hippocampi were analyzed for citrate, α-ketoglutarate, and amino acids. In the hippocampi of the Ket-fed mice, there were higher concentrations of citrate and α-ketoglutarate as well as higher concentrations of glutamate, aspartate and n-acetyl-aspartate compared with controls. There were positive associations between (1) concentrations of aspartate and n-acetyl-aspartate (n = 14, R = 0.9327), and (2) α-ketoglutarate and glutamate (n = 14, R = 0.8521) in animals maintained on either diet. Hippocampal n-acetyl-aspartate predicted the outcome of several exploratory and avoidance-related behaviors. Ketosis restored citrate and α-ketoglutarate in the hippocampi of aging mice. Higher concentrations of n-acetyl-aspartate corresponded with greater exploratory activity and reduced avoidance-related behavior.


  • Open Access

    Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease

    by Robert J. Pawlosky, Martin F. Kemper, Yoshihero Kashiwaya, Michael Todd King, Mark P. Mattson, Richard L. Veech

    In patients with Alzheimer's disease (AD) and in a triple transgenic (3xTgAD) mouse model of AD low glucose metabolism in the brain precedes loss of memory and cognitive decline. The metabolism of ketones in the brain by‐passes glycolysis and therefore may correct several deficiencies that are associated with glucose hypometabolism. A dietary supplement composed of an ester of D‐β‐hydroxybutyrate and R‐1,3 butane diol referred to as ketone ester (KE) was incorporated into a rodent diet and fed to 3xTgAD mice for 8 months. At 16.5 months of age animals were killed and brains dissected. Analyses were carried out on the hippocampus and frontal cortex for glycolytic and TCA (Tricarboxylic Acid) cycle intermediates, amino acids, oxidized lipids and proteins, and enzymes. There were higher concentrations of d‐β‐hydroxybutyrate in the hippocampus of KE‐fed mice where there were also higher concentrations of TCA cycle and glycolytic intermediates and the energy‐linked biomarker, N‐acetyl aspartate compared to controls. In the hippocampi of control‐fed animals the free mitochondrial [NAD+]/[NADH] ratio were highly oxidized, whereas, in KE‐fed animals the mitochondria were reduced. Also, the levels of oxidized protein and lipids were lower and the energy of ATP hydrolysis was greater compared to controls. 3xTgAD mice maintained on a KE‐supplemented diet had higher concentrations of glycolytic and TCA cycle metabolites, a more reduced mitochondrial redox potential, and lower amounts of oxidized lipids and proteins in their hippocampi compared to controls. The KE offers a potential therapy to counter fundamental metabolic deficits common to patients and transgenic models. image Read the Editorial Highlight for this article on page 162.


  • Open Access

    Compartmental analyses of 2H5-α-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n−3 in newborn term infants

    by Yu Hong Lin, Adolfo Llanos, Patricia Mena, Ricardo Uauy, Norman Salem, Robert J Pawlosky

    Background: During early postnatal development, the nervous system accretes docosahexaenoic acid (DHA; 22:6n−3), a highly unsaturated n−3 (omega-3) f


  • Alterations in Brain Glucose Utilization Accompanying Elevations in Blood Ethanol and Acetate Concentrations in the Rat

    by Robert J. Pawlosky, Yoshihiro Kashiwaya, Shireesh Srivastava, Michael T. King, Calvin Crutchfield, Nora Volkow, George Kunos, Ting‐Kai Li, Richard L. Veech

    Background:  Previous studies in humans have shown that alcohol consumption decreased the rate of brain glucose utilization. We investigated whether the major metabolite of ethanol, acetate, could account for this observation by providing an alternate to glucose as an energy substrate for brain and the metabolic consequences of that shift.Methods:  Rats were infused with solutions of sodium acetate, ethanol, or saline containing 13C‐2‐glucose as a tracer elevating the blood ethanol (BEC) and blood acetate (BAcC) concentrations. After an hour, blood was sampled and the brains of animals were removed by freeze blowing. Tissue samples were analyzed for the intermediates of glucose metabolism, Krebs’ cycle, acyl‐coenzyme A (CoA) compounds, and amino acids.Results:  Mean peak BEC and BAcC were approximately 25 and 0.8 mM, respectively, in ethanol‐infused animals. Peak blood BAcC increased to 12 mM in acetate‐infused animals. Both ethanol and acetate infused animals had a lower uptake of 13C‐glucose into the brain compared to controls and the concentration of brain 13C‐glucose‐6‐phosphate varied inversely with the BAcC. There were higher concentrations of brain malonyl‐CoA and somewhat lower levels of free Mg2+ in ethanol‐treated animals compared to saline controls. In acetate‐infused animals the concentrations of brain lactate, α‐ketoglutarate, and fumarate were higher. Moreover, the free cytosolic [NAD+]/[NADH] was lower, the free mitochondrial [NAD+]/[NADH] and [CoQ]/[CoQH2] were oxidized and the ΔG′ of ATP lowered by acetate infusion from −61.4 kJ to −59.9 kJ/mol.Conclusions:  Animals with elevated levels of blood ethanol or acetate had decreased 13C‐glucose uptake into the brain. In acetate‐infused animals elevated BAcC were associated with a decrease in 13C‐glucose phosphorylation. The co‐ordinate decrease in free cytosolic NAD, oxidation of mitochondrial NAD and Q couples and the decrease in ΔG′ of ATP was similar to administration of uncoupling agents indicating that the metabolism of acetate in brain caused the mitochondrial voltage dependent pore to form.


  • Compartmental Analyses of Plasma 13C- and 2H-Labeled n-6 Fatty Acids Arising from Oral Administrations of 13C-U-18:2n-6 and 2H5-20:3n-6 in Newborn Infants

    by Robert J Pawlosky, Yu Hong Lin, Adolfo Llanos, Patricia Mena, Ricardo Uauy, Norman Salem

    Efficacy of 13C-U-18:2n-6 and 2H5-20:3n-6 toward synthesis of labeled-20:4n-6 was studied in newborn infants utilizing compartmental models of plasma labeled n-6 fatty acids (FA). Ten infants received oral doses of 13C-U-18:2n-6 and 2H5-20:3n-6 ethyl esters (100 and 2 mg/kg, respectively). Rate constant coefficients and half-lives (t½) of n-6 FA were determined from the time-course concentrations of labeled-FA. Plasma n-6 FA values approximated steady state concentrations. Synthetic and utilization rates were calculated. Eight percent (range, 2–21%) of plasma 13C-U-18:2n-6 was used for synthesis of 13C-18:3n-6, -20:2n-6, and -20:3n-6. Seventy percent of 13C-20:3n-6 (mean, CV: 0.26) was available for synthesis of 13C-20:4n-6. The percentage of 2H5-20:3n-6 converted to 2H5-20:4n-6 was lower (mean: 26%, p < 0.02) than the 13C-labeled analogue. Turnover of 18:2n-6 in subjects and of 20:4n-6 in plasma was 4.2 g/kg/d (CV: 0.58) and 4.3 mg/kg/d (CV: 0.81), respectively. Intake of 18:2n-6 and 20:4n-6 were estimated to be 3.0 g/kg/d (±1.7) and 2.8 mg/kg/d (± 2.2), respectively. Infants required additional 18:2n-6 and 20:4n-6 (mean: 1.2 g and 1.5 mg/kg/d) above predicted intake amounts to maintain plasma concentrations of 18:2n-6 and 20:4n-6, in order to spare FA from fat stores.


  • Development of Alcoholic Fatty Liver and Fibrosis in Rhesus Monkeys Fed a Low n‐3 Fatty Acid Diet

    by Robert J. Pawlosky, Norman Salem

    Background: The amount and type of dietary fat seem to be important factors that modulate the development of alcohol‐induced liver steatosis and fibrosis. Various alcohol‐feeding studies in animals have been used to model some of the symptoms that occur in liver disease in humans.Methods: Rhesus monkeys (Macaca mulatta) were maintained on a diet that had a very low concentration of α‐linolenic acid and were given free access to an artificially sweetened 7% ethanol solution. Control and ethanol‐consuming animals were maintained on a diet in which the linoleate content was adequate (1.4% of energy); however, α‐linoleate represented only 0.08% of energy. Liver specimens were obtained, and the fatty acid composition of the liver phospholipids, cholesterol esters, and triglycerides of the two groups were compared at 5 years and histopathology of tissue samples were compared at 3 and 5 years.Results: The mean consumption of ethanol for this group over a 5‐year period was 2.4 g · kg−1· day−1. As a consequence of the ethanol‐dietary treatment, there were significantly lower concentrations of several polyunsaturated fatty acids in the liver phospholipids of the alcohol‐treated group, including arachidonic acid and most of the n‐3 fatty acids and particularly docosahexaenoic acid, when compared with dietary controls. Liver specimens from animals in the ethanol group at 5 years showed a marked degree of steatosis, both focal and diffuse cellular necrosis, and an increase in the development of fibrosis compared with specimens obtained at 3 years and with those from dietary controls, in which there was no evidence of fibrotic lesions.Conclusion: These findings suggest that the advancement of ethanol‐induced liver disease in rhesus monkeys may be modulated by the amount and type of dietary essential fatty acids and that a marginal intake of n‐3 fatty acids may be a permissive factor in the development of liver disease in primates.


  • A Mass Spectrometric Validated High-Performance Liquid Chromatography Procedure for the Determination of Folates in Foods

    by Robert J. Pawlosky, Vincent P. Flanagan, Robert F. Doherty

    A series of five food reference materials (RM) that had certified values of folate concentrations and five frozen food samples were analyzed for 5-methyltetrahydrofolic acid (5-MTHFA) and folic acid (FA) using a high-performance liquid chromatography (HPLC) method with fluorescence detection that was validated using an HPLC mass spectrometry (MS) method with electrospray ionization. Identical sample specimens were extracted and analyzed in triplicate using both instrumental methods, and a comparison was made of the mean values of 5-MTHFA and FA resulting from these determinations. The analytes were isolated on either a high capacity strong anion exchange solid phase extraction column (HPLC method) or a phenyl Bond Elut column (MS method) prior to analyses. For quantification of the analytes by MS, (13)C-labeled 5-MTHFA and FA were added to samples as internal standards prior to enzymatic digestion and conversion of the polyglutamate forms of 5-MTHFA to the monoglutamic acid. Quantification of FA and 5-MTHFA using the HPLC analysis was carried out using external standards. With the exception of one RM (pig liver), the values established for 5-MTHFA using these methods were highly comparable. In determining the variance associated with these two procedures, it was observed that the mean relative standard error for 5-MTHFA was 12 (range, 2-27%) and 11% (range, 5-25%) for the HPLC and MS methods, respectively. FA was detected in only three of the samples, and the values obtained for it by either method were similar. This is the first paper that describes a mass spectrometric method used in the validation of an HPLC determination of food folates across a wide range of sample matrixes. The comparable values for 5-MTHFA and FA suggest that HPLC analysis with fluorescent detection may be used to accurately quantify folates present in a variety of food matrixes.